ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

OPTI Optibiotix Health Plc

18.00
0.00 (0.00%)
03 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Optibiotix Health Plc LSE:OPTI London Ordinary Share GB00BP0RTP38 ORD 2P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 18.00 17.50 18.50 18.00 18.00 18.00 66,018 08:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Noncomml Resh Organizations 457k 2.59M 0.0284 6.34 16.41M
Optibiotix Health Plc is listed in the Noncomml Resh Organizations sector of the London Stock Exchange with ticker OPTI. The last closing price for Optibiotix Health was 18p. Over the last year, Optibiotix Health shares have traded in a share price range of 5.75p to 43.50p.

Optibiotix Health currently has 91,190,661 shares in issue. The market capitalisation of Optibiotix Health is £16.41 million. Optibiotix Health has a price to earnings ratio (PE ratio) of 6.34.

Optibiotix Health Share Discussion Threads

Showing 94776 to 94795 of 147575 messages
Chat Pages: Latest  3803  3802  3801  3800  3799  3798  3797  3796  3795  3794  3793  3792  Older
DateSubjectAuthorDiscuss
11/8/2020
08:22
precursor to a cash raise ??
buywell3
11/8/2020
08:21
Same here. 👉🏾🤮💩c75;
rayrac
11/8/2020
08:20
Off out. No ranc, no point
kreature
11/8/2020
08:13
Great rns, building very nicely indeed
robo28
11/8/2020
08:13
Maybe extend that into flatulence disorders ?
kreature
11/8/2020
08:07
“The Company has been awarded (subject to contract) a grant to explore the effect of LP(LDL) (R) on stress, anxiety, and sleep disorders with Universities in the UK and Europe“

The directors taking advantage of this effect?...could help?

Subject to contract of course

rayrac
11/8/2020
07:59
no financials in commercial update? as ranc as ever. Hence think I will delay buying shares today
kreature
11/8/2020
07:51
for disappointment
kreature
11/8/2020
07:50
H2 recognised revenues expected to be far greater than H1, so massive potential.
kreature
11/8/2020
07:50
Ooooh..never that surely? Rumbled?
rayrac
11/8/2020
07:47
On the basis of a lack of money ? lack of profit ?
kreature
11/8/2020
07:45
:)) on what basis? Lack of potential?
rayrac
11/8/2020
07:39
Doubt it though. Would it be prudent to raise some more cash at this point, at least enough to fund the interviews and RNS releases ?
kreature
11/8/2020
07:34
Probably just phase 1 ?
kreature
11/8/2020
07:32
creates the potential for LPLDL® to be commercialised as a pharmaceutical drug product’

They putting it through phase 1/2/3 trials then?

rayrac
11/8/2020
07:30
Lol! Never thought of that!
rayrac
11/8/2020
07:29
‘ creates the potential for LPLDL® to be commercialised as a pharmaceutical drug product’

Amazeballs. ....and creates the potential for a second wave placing ?

kreature
Chat Pages: Latest  3803  3802  3801  3800  3799  3798  3797  3796  3795  3794  3793  3792  Older

Your Recent History

Delayed Upgrade Clock